Holen Sie sich die Stockscreener-App
10.19
0.00%
0.00
Helix Acquisition Corp Iii Aktie (HLXC) Neueste Nachrichten
A | Is Helix Acquisition Corp. II on track to beat earningsMarket Activity Recap & Capital Efficient Trading Techniques - mfd.ru
Can AIFER ride the EV waveQuarterly Profit Review & Free Long-Term Investment Growth Plans - mfd.ru
Newsroom - White & Case LLP
Helix Acquisition Corp. III completes $172.5 million IPO and private placement - Investing.com Nigeria
Helix Acquisition Corp. III Completes Initial Public Offering - TradingView
Finance Watch: SPACs Attempt A Comeback As IPO Market Shows Signs Of Life - Citeline News & Insights
With a Thin IPO Calendar, Hedge Funds Are Zeroing In on Biopharma - Institutional Investor
Helix Acquisition prices $150M initial public offering - MSN
Will Helix Acquisition Corp. II stock continue dividend increasesRate Cut & AI Forecast Swing Trade Picks - mfd.ru
Helix Acquisition Corp. III raises $172.5 million in Nasdaq IPO By Investing.com - Investing.com Nigeria
Helix Acquisition Corp III closes $172.5 million IPO By Investing.com - Investing.com South Africa
Helix Acquisition Corp. III closes $172.5 million IPO By Investing.com - Investing.com Australia
Helix Acquisition Corp. III raises $172.5 million in Nasdaq IPO - Investing.com
Helix Acquisition Corp. III closes $172.5 million IPO - Investing.com India
Helix Acquisition Corp. III Announces Closing of $172.5 Million Initial Public Offering, Including the Full Exercise of the Underwriter's Option to Purchase Additional Shares - The Manila Times
SL Green Realty Corp. Announces Date of 2026 Annual Meeting of Stockholders - The Manila Times
Helix Acquisition Corp III closes $172.5 million IPO - Investing.com
White & Case advises Helix Acquisition Corp. III on upsized US$150 million IPO - White & Case LLP
Biotech investor Cormorant secures $150M for another SPAC deal - BioPharma Dive
Insider Buy: Does Unusual Machines Inc align with a passive investing strategyTrade Entry Report & Low Risk Investment Opportunities - baoquankhu1.vn
Helix Acquisition III Raises $150 Million, Targets Healthcare Sector - intellectia.ai
Helix Acquisition Corp. III Prices Upsized $150 Mln IPO - Nasdaq
Helix Acquisition Corp. III Announces Pricing of Upsized $150 Million Initial Public Offering - The Manila Times
Day One was one of three parties interested in Mersana; Bihua Chen and Cormorant’s third SPAC - Endpoints News
HLXC IPO NewsCormorant's SPAC Helix Acquisition III files for a $125 million IPO, targeting healthcare - renaissancecapital.com
BBOT Reports Third Quarter 2025 Financial Results and Update on Corporate Progress - GlobeNewswire
BridgeBio Oncology stock initiated with Outperform rating at Oppenheimer - Investing.com
SPACs Line Up To Clear Biotech’s IPO Backlog - BioSpace
Helix Acquisition Corp. II Completes Merger with BridgeBio - The Globe and Mail
Cantor Fitzgerald initiates BridgeBio Oncology stock with Overweight rating By Investing.com - Investing.com Nigeria
BBOT Debuts as a Publicly Traded Company Focused on RAS-Pathway Malignances with a Potential to Realize the Full Promise of KRAS and PI3K Inhibition - GlobeNewswire
Helix Acquisition Corp. II Retains More than 60% of Trust Account after Redemptions in connection with Business Combination with BridgeBio Oncology Therapeutics - FinancialContent
BBOT Appoints Industry Veteran Uneek Mehra as Chief Financial Officer - Business Wire
BridgeBio Oncology's SPAC Merger Advances: SEC Clears Path for Novel Cancer Drug Development Platform - Stock Titan
Longevity Biotech Takes Root on Nasdaq With $180M SPAC Deal - BioSpace
Big Law Firms Wary of SPAC Rebound Seek to Get Paid This Time - Bloomberg Law News
Helix BioPharma (TSX: "HBP", OTC PINK: "HBPCD", FRANKFURT: "HBP0") Secures Pre-IND Candidates LEUMUNA(TM) and GEMCEDA(TM) in Strategic Acquisition from the Laevoroc Group - TheNewswire
Helix Acquisition Corp. II SEC 10-Q Report - TradingView
German cancer antibody biotech eyes SPAC as route to Nasdaq - Fierce Biotech
Bay Area VC-funded life sciences companies raised over $5 billion in 2024 - The Business Journals
Checkpoint checks out | ApexOncoClinical Trials news and analysis - Oncology Pipeline
BridgeBio spin-out in SPAC deal to target RAS and PI3Kα malignancies - The Pharma Letter
BridgeBio spinout to go public in SPAC deal with Helix Acquisition Corp. II - MSN
BridgeBio oncology spinout to go public in blank-check merger - BioPharma Dive
Life Sciences Hedge Fund Perceptive Preps a New SPAC - Institutional Investor
Helix Acquisition Corp. II Closes of $184 Million IPO - citybiz
Helix Acquisition Corp. II Prices of Upsized $160 Million IPO - citybiz
Cormorant Launches Second SPAC Following MoonLake Deal with $100M IPO - BioSpace
MoonLake Immunotherapeutics goes public via SPAC - Startupticker.ch
Moonlake going after blockbuster indications with dual-targeting nanobody - BioWorld MedTech
SPAC Market Remains Hot as MoonLake Therapeutics Hits the Nasdaq - BioSpace
Esports Entertainment Group Completes Acquisition of Helix eSports and ggCircuit - TMX Newsfile
Helix Acquisition Corp. Announces Closing of $115 Million Initial Public Offering, Including the Full Exercise of the Underwriter's Option to Purchase Additional Shares - TMX Newsfile
0.00%
0.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):